Document Detail


Monitoring the Safety of Medicines Used Off-Label.
MedLine Citation:
PMID:  22472983     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Off-label use of medicines is common. Because many off-label uses have not been carefully studied, it is important that postmarketing drug safety systems be able to identify, assess, and monitor adverse events that occur in the off-label setting. The full range of postmarketing surveillance and analysis tools can be utilized to study the adverse effects of medicines used off-label.
Authors:
G J Dal Pan
Related Documents :
8330393 - Can medical decisions be standardized? should they be?
18855623 - Enkephalinase inhibitors: potential agents for the management of pain.
12457473 - A survey of attitudes to abortion law in northern ireland amongst obstetricians, gynaec...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-04
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  -     ISSN:  1532-6535     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Office of Surveillance and Epidemiology, US Food and Drug Administration, Silver Spring, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Shape-controlled tunable homochromatic luminescence and inner photoelectric effect of hexagonal Na(1...
Next Document:  The Use of Observational Health-Care Data to Identify and Report on Off-Label Use of Biopharmaceutic...